Skip to main content
. 2022 Dec 2;10(2):e200072. doi: 10.1212/NXI.0000000000200072

Figure 2. Analysis of Diagnostic Utility of Serum Oligomerization Domain–Containing Protein 2 (NOD2) and Osteopontin (Spp1) Through Receiver Operating Characteristic (ROC) Curves.

Figure 2

Sensitivity and specificity of serum (A) oligomerization domain–containing protein 2 (NOD2) and (B) osteopontin (Spp1) levels in patients with ALS and healthy controls. ALS = amyotrophic lateral sclerosis; HC = healthy control.